These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3559161

  • 1. Depot neuroleptics and manic depressive psychosis.
    Lowe MR, Batchelor DH.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():53-62. PubMed ID: 3559161
    [Abstract] [Full Text] [Related]

  • 2. Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients.
    Malempati RN, Bond DJ, Yatham LN.
    Int Clin Psychopharmacol; 2008 Mar; 23(2):88-94. PubMed ID: 18301123
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
    Gelders YG.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
    [Abstract] [Full Text] [Related]

  • 4. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN, Wazome EG.
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract] [Full Text] [Related]

  • 5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Dec; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 8. Rapid cycling disorders and the role of combined lithium and haloperidol decanoate.
    Loew MR.
    Can J Psychiatry; 1986 Dec; 31(9):877-8. PubMed ID: 3542181
    [No Abstract] [Full Text] [Related]

  • 9. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE, Kleindienst N, Evoniuk G, Bowden C, Möller HJ, Bohus M, Frangou S, Greil W, Calabrese JR.
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [Abstract] [Full Text] [Related]

  • 10. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC, Jann MW, Lin HN, Piao-Chien C, Chang WH.
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [Abstract] [Full Text] [Related]

  • 11. Flupenthixol versus haloperidol in acute psychosis.
    Parent M, Toussaint C.
    Pharmatherapeutica; 1983 Jul; 3(5):354-64. PubMed ID: 6844372
    [Abstract] [Full Text] [Related]

  • 12. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
    Cesková E, Svestka J, Rysánek R.
    Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
    [Abstract] [Full Text] [Related]

  • 13. Experience with depot neuroleptics in ambulatory practice.
    Fiolet J.
    Acta Psychiatr Belg; 1981 Jan; 81(2):182-8. PubMed ID: 6117188
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of depot neuroleptic haloperidol decanoate.
    Fernando J, Krishna Raju R, Jones GG, Stanley RO.
    Acta Psychiatr Scand; 1984 Feb; 69(2):175-6. PubMed ID: 6702478
    [Abstract] [Full Text] [Related]

  • 16. The effect of haloperidol on serum levels of lithium in adult manic patients.
    Schaffer CB, Batra K, Garvey MJ, Mungas DM, Schaffer LC.
    Biol Psychiatry; 1984 Oct; 19(10):1495-9. PubMed ID: 6440599
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [Abstract] [Full Text] [Related]

  • 18. Lithium combined with carbamazepine or haloperidol in the treatment of mania.
    Small JG, Klapper MH, Marhenke JD, Milstein V, Woodham GC, Kellams JJ.
    Psychopharmacol Bull; 1995 Aug; 31(2):265-72. PubMed ID: 7491378
    [Abstract] [Full Text] [Related]

  • 19. Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological control.
    Read SG, Batchelor DH.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():63-74. PubMed ID: 3559162
    [Abstract] [Full Text] [Related]

  • 20. Antimanic effect of clonazepam.
    Chouinard G, Young SN, Annable L.
    Biol Psychiatry; 1983 Apr; 18(4):451-66. PubMed ID: 6407539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.